Challenges in interpretation of thyroid hormone test results.

INTRODUCTION In interpreting thyroid hormones results it is preferable to think of interference and changes in concentration of their carrier proteins. OUTLINE OF CASES We present two patients with discrepancy between the results of thyroid function tests and clinical status. The first case presents a 62-year-old patient with a nodular goiter and Hashimoto thyroiditis. Thyroid function test showed low thyroid-stimulating hormone (TSH) and normal to low fT4. By determining thyroid status (TSH, T4, fT4,T3, fT3) in two laboratories, basal and after dilution, as well as thyroxine-binding globulin (TBG), it was concluded that the thyroid hormone levels were normal. The results were influenced by heterophile antibodies leading to a false lower TSH level and suspected secondary hypothyroidism.The second case, a 40-year-old patient, was examined and followed because of the variable size thyroid nodule and initially borderline elevated TSH, after which thyroid status showed low level of total thyroid hormones and normal TSH. Based on additional analysis it was concluded that low T4 and T3 were a result of low TBG. It is a hereditary genetic disorder with no clinical significance. CONCLUSION Erroneous diagnosis of thyroid disorders and potentially harmful treatment could be avoided by proving the interference or TBG deficiency whenever there is a discrepancy between the thyroid function results and the clinical picture.

[1]  H. Targovnik,et al.  Novel Mutation p.A64D in the Serpina7 Gene as a Cause of Partial Thyroxine-binding Globulin Deficiency Associated with Increases Affinity in Transthyretin by a Known p.A109T Mutation in the TTR Gene , 2013, Hormone and Metabolic Research.

[2]  K. Nustad,et al.  Heterophilic antibody interference in immunometric assays. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[3]  C. Spencer.  Assay of Thyroid Hormones and Related Substances , 2013 .

[4]  Beatrice Hull.  Aberrantly elevated TSH level due to human anti-mouse antibodies (HAMA) interference with thyrotropin assay. , 2012, Journal of the South Carolina Medical Association.

[5]  C. Sturgeon,et al.  Analytical error and interference in immunoassay: minimizing risk , 2011, Annals of clinical biochemistry.

[6]  R. M. Azad.  Abnormal serum thyroid hormones concentration with healthy functional gland: a review on the metabolic role of thyroid hormones transporter proteins. , 2011, Pakistan journal of biological sciences : PJBS.

[7]  R. Domingues,et al.  A novel variant in Serpina7 gene in a family with thyroxine-binding globulin deficiency , 2009, Endocrine.

[8]  E. Randell,et al.  Exacerbation of underlying hypothyroidism caused by proteinuria and induction of urinary thyroxine loss: case report and subsequent investigation. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  F. Sweep,et al.  Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies. , 2007, The International journal of biological markers.

[10]  G. Beckett,et al.  Thyroid guidelines - are thyroid-stimulating hormone assays fit for purpose? , 2007, Annals of clinical biochemistry.

[11]  Sunil Krishnan,et al.  Falsely raised TSH levels due to human anti-mouse antibody interfering with thyrotropin assay , 2006, Postgraduate Medical Journal.

[12]  S. Djurica,et al.  [Diagnosis of autoimmune thyroid disease]. , 2005, Srpski arhiv za celokupno lekarstvo.

[13]  U. Roggenbuck,et al.  Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. , 2005, Thyroid : official journal of the American Thyroid Association.

[14]  W. Oyen,et al.  Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies. , 2004, Cancer biotherapy & radiopharmaceuticals.

[15]  S. Emerson,et al.  Screening for interference in immunoassays. , 2003, Clinical chemistry.

[16]  C. Chiu,et al.  Two novel mutations in the gene encoding thyroxine‐binding globulin (TBG) as a cause of complete TBG deficiency in Taiwan , 2003, Clinical endocrinology.

[17]  A. Price,et al.  Functional sensitivity and recovery of thyroid-stimulating hormone. , 2001, Clinical chemistry.

[18]  L. Ward,et al.  Thyroid stimulating hormone levels in cord blood are not influenced by non-thyroidal mothers' diseases. , 2000, Sao Paulo medical journal = Revista paulista de medicina.

[19]  N. Després,et al.  Antibody interference in thyroid assays: a potential for clinical misinformation. , 1998, Clinical chemistry.

[20]  R. G. Gaines Das,et al.  Invalidity from nonparallelism in a radioimmunoassay for erythropoietin accounted for by human serum antibodies to rabbit IgG. , 1993, Experimental hematology.

[21]  M. Brennan,et al.  Heterophilic serum antibodies: a cause for falsely elevated serum thyrotropin levels. , 1987, Mayo Clinic proceedings.

[22]  T. Kigoshi,et al.  [Thyroxine-binding globulin deficiency in a family]. , 1983, Nihon Naibunpi Gakkai zasshi.

[23]  G. Loeuille,et al.  Congenital Thyroid Binding Globulin (TBG) deficiency. Its incidence on a screening program for neonatal hypothyroidism: 92 , 1980, Pediatric Research.